ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

IHC Inspiration Healthcare Group Plc

30.50
-0.50 (-1.61%)
Last Updated: 15:00:53
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Inspiration Healthcare Group Plc LSE:IHC London Ordinary Share GB00BXDZL105 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50 -1.61% 30.50 30.00 31.00 31.00 30.30 31.00 13,390 15:00:53
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Home Health Care Services 41.23M 272k 0.0040 76.25 20.8M
Inspiration Healthcare Group Plc is listed in the Home Health Care Services sector of the London Stock Exchange with ticker IHC. The last closing price for Inspiration Healthcare was 31p. Over the last year, Inspiration Healthcare shares have traded in a share price range of 28.00p to 57.50p.

Inspiration Healthcare currently has 68,198,333 shares in issue. The market capitalisation of Inspiration Healthcare is £20.80 million. Inspiration Healthcare has a price to earnings ratio (PE ratio) of 76.25.

Inspiration Healthcare Share Discussion Threads

Showing 676 to 697 of 950 messages
Chat Pages: 38  37  36  35  34  33  32  31  30  29  28  27  Older
DateSubjectAuthorDiscuss
06/7/2020
14:23
I had my IHC shares in 5 different accounts, Sipp and ISAs, also applied for more in each one.
The OO shares 1 for 50 will be allocated to those that applied for them, then there will be those that didn't and these shares will be offered to the excess share applicants, however they will be issued on a pro rata basis, so if someone asks for the same amount again and someone else asks for 4 times the amount, the latter will get more. The oversubscription doesn't seem too high so am hoping a lot did not take up the OO and those that wanted excess will get a fair few of them.

troutisout
06/7/2020
14:11
Informative posts above, cheers.

Troutisout, I always find it impossible to predict what allocations I'll get from Open Offers! Barclays (as a consolidator) always seem to get much better allocations than they should, so I'm often quite pleasantly surprised....

rivaldo
06/7/2020
14:01
The UK production has stopped, but IHC's involvement will continue as they are manning the 24hr helpline, which will be needed for months to come.
Penlon have now been granted CE approval for their ES02 ventilator and so are continuing to produce them for export markets. Amazing to think the consortium ended up producing more in a day, than in ten months of Penlon production pre COVID.
The real benefit for the companies involved will have been working with different companies in the supply chain, both smaller and much larger and the respect gained for each other and the co-operation involved will lead to more business between them in the future.

troutisout
06/7/2020
13:51
Ventilator challenge announced that they have shipped the last of the 13,400 ventilators built for the NHS on 5 July. Great achievement of the consortium which included IHC.
geovest
06/7/2020
13:45
rivaldo, difficult to work out what any excess allocation we will all get?
troutisout
06/7/2020
13:44
All passed and Open Offer oversubscribed.
troutisout
06/7/2020
13:35
Fundraising approved - and the Open Offer oversubscribed. Hope I got a decent allocation....
rivaldo
29/6/2020
05:27
tinyurl.com/yckf5fch
#BOOOOOOOOOOOOOMM #N4P
@n4pharma

- £186 million government funding from UK Research and Innovation’ - Evotec are involved, i think Nigel has played a blinder here by getting Evo to do the proofing work

paleales
26/6/2020
07:44
Indeed - some quotes this morning read extremely well:

"As I announced at the time of our annual results in April, the Group had enjoyed a very strong start to the year with increased revenues and a healthy order book and I can report that this high level of activity continued during the last few months and including the Covid-19 epidemic."

Re the SLE acquisition:

"The proposed acquisition is expected to be earnings enhancing in the short to medium term, with significant commercial synergies. Additionally, it will broaden the Group's product portfolio and geographic reach."

"To this end, I'm confident that we will continue the good start we have made so far this year and are set once again to increase revenues significantly."

rivaldo
26/6/2020
07:08
Very positive AGM statement with the strong start having continued in more recent months.That should surely lead to an upgrade from the broker who had retained the earlier guidance.
hastings
24/6/2020
15:54
Thanks Geovest.
shauney2
24/6/2020
15:41
Cenkos has published a comprehensive 30 page research note that covers the acquisition. If you are interested, go to Cencos.com and sign up for access to their research portal where you will find the note.
geovest
24/6/2020
15:07
Let's try this for a direct link to the CEO's interview:
rivaldo
23/6/2020
15:51
"This is a significant step in the firm’s ambition to reach £100m revenue through organic growth and acquisitions, and the aim to become a global leader in neonatal intensive care equipment."
troutisout
23/6/2020
12:31
CEO interview, cut and paste as won't let me post website link....

tinyurl.com/y8ppkol5

troutisout
19/6/2020
12:58
Thanks Geovest
firtashia
19/6/2020
12:11
a small discount to the current price- but i suspect that it is the fact of this placing that has been holding back the share price while good news has been pouring out of the last few months.

i suspect that without the placing in the background, the price would have forged ahead, so it is an a more signifcant "real" discount than it looks.

still good news though, imho

lfc4ever
19/6/2020
11:44
SLE's Balance Sheet looks good. Net assets of around £10m in 2019, so probably around £11 - 12m now. No intangibles on their Balance Sheet. No debt. All looks very clean.
You can find the detailed accounts on the Companies House website.

geovest
19/6/2020
10:32
SLE's revs and EBITDA are not too dissimilar from IHCs- almost a merger between 2 companies of similar size. IHC is paying £18m for SLE, IHC's market cap currently £27m. If you still believe IHC is decent value at these levels then their purchase is a good one from a value perspective. Would like to see SLE's balance sheet though.
firtashia
19/6/2020
10:09
The discount is 1.5%, so dilution very small to existing shareholders, existing shareholders can use the OO to increase their holding by 2% covering all dilution.
There has been ample time for shareholders to increase their holdings at 65p or below in the market these past couple of months.

troutisout
19/6/2020
09:38
But stingy on 1 for 50, I have 10000 so would only be entitled to buy 200 !!!!
Should have made it a minimum of say 500 and at least make it a bit more worthwhile.
Heyho .

oohrogerpalmer
19/6/2020
09:26
Not concerned about the small retail element as I feel holder's will be well rewarded as we move forward.Cenkos very bullish on the deal and prospects.
hastings
Chat Pages: 38  37  36  35  34  33  32  31  30  29  28  27  Older

Your Recent History

Delayed Upgrade Clock